Update on inoperable lung cancer and mesothelioma

Presented by Dr Sanjay Popat, Senior Lecturer & Honorary Consultant in Medical Oncology.

Dr Sanjay Popat
Dr Sanjay Popat

Dr Popat is a clinical senior lecturer at the National Heart and Lung Institute and honorary consultant thoracic medical oncologist at The Royal Marsden. He qualified in 1994 and completed medical oncology training at The Royal Marsden. Dr Popat has published in the fields of genetics, therapeutic biomarkers and medical oncology.

Here he discusses:

  • Developments in the management of advanced non small-cell lung cancer
  • The latest therapeutic advances and managing their side-effects
  • The gene mutation that predisposes patients to respond well to therapy
  • Use and limitations of the monoclonal antibody bevacizumab
  • Treatment of small-cell lung cancer

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus